NASDAQ:ESLA | Cash Flow Statement | Estrella Immunopharma, Inc.

Complete source-backed cash-flow history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$2.31M
2026-03-31-$2.29M-$6.7M$7.24M
2025-12-31-$613,174.00-$177,487.00-$64,821.00
2025-09-30-$4.8M
2025-06-30-$5.54M
2025-03-31-$2.1M-$465,981.00-$29,462.00
2024-09-30-$3.38M-$2.22M-$150,465.00
2024-06-30-$3.95M-$291,513.00$0.00-$270,349.00
2024-03-31-$469,530.00-$4.23M-$84,091.00
2023-12-31-$1.02M
2023-09-30-$1.87M-$275,192.00-$112,298.00$20.05M
2023-06-30-$2.73M-$43,245.00-$136,533.00
2023-03-31-$2.74M-$275,718.00$77,773.00$186,533.00
2022-12-31-$2.76M-$140,132.00-$36.06M
2022-09-30-$2.89M-$1.1M
2022-06-30-$359,586.00
2022-03-31-$141,252.00-$157,144.00
2021-12-31-$135,797.00-$293,300.00$0.00$0.00
2021-09-30-$107,547.00
2021-06-30-$3,555.00
2021-03-31-$819.00-$819.00$42,896.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$13.06M-$1.79M$2.25M
2024-06-30-$7.31M-$16.07M$4.96M$12.79M
2023-06-30-$11.11M-$1.34M-$273,066.00
2022-12-31-$996,104.00-$1.04M$36.17M-$35.56M
2021-12-31-$247,718.00-$316,158.00-$45.19M$45.98M